Ma L - Search Results

1

Resveratrol inhibits STAT5 activation through the induction of SHP-1 and SHP-2 tyrosine phosphatases in chronic myelogenous leukemia cells.

Li Q, Zhang L, Ma L, Bai X, Li X, Zhao M, Sui T. Li Q, et al. Among authors: ma l. Anticancer Drugs. 2018 Aug;29(7):646-651. doi: 10.1097/CAD.0000000000000635. Anticancer Drugs. 2018. PMID: 29878900

2

Resveratrol inhibits the phosphatidylinositide 3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway in the human chronic myeloid leukemia K562 cell line.

Sui T, Ma L, Bai X, Li Q, Xu X. Sui T, et al. Among authors: ma l. Oncol Lett. 2014 Jun;7(6):2093-2098. doi: 10.3892/ol.2014.2014. Epub 2014 Mar 28. Oncol Lett. 2014. PMID: 24932295 Free PMC article.

3

[Plasma microRNA profile in immune thrombocytopenia: screening and verification].

Sui T, Ma L, Li X, Li Q, Bai X, Mu J, Zhao M. Sui T, et al. Among authors: ma l. Zhonghua Yi Xue Za Zhi. 2014 Apr 15;94(14):1083-6. Zhonghua Yi Xue Za Zhi. 2014. PMID: 24851893 Chinese.

4

[Reactive oxygen species mediate the injury and deficient hematopoietic supportive capacity of umbilical cord derived mesenchymal stem cells induced by iron overload].

Lu WY, Zhao MF, Chai X, Meng JX, Zhao N, Rajbhandary S, Xu XN, Ma L, Li YM. Lu WY, et al. Among authors: ma l. Zhonghua Yi Xue Za Zhi. 2013 Mar 26;93(12):930-4. Zhonghua Yi Xue Za Zhi. 2013. PMID: 23863680 Chinese.

5

Anti-CD19 CAR-T as a feasible and safe treatment against central nervous system leukemia after intrathecal chemotherapy in adults with relapsed or refractory B-ALL.

He X, Xiao X, Li Q, Jiang Y, Cao Y, Sun R, Jin X, Yuan T, Meng J, Ma L, Lu W, Lyu C, Liu K, Zhao M. He X, et al. Among authors: ma l. Leukemia. 2019 Aug;33(8):2102-2104. doi: 10.1038/s41375-019-0437-5. Epub 2019 Mar 7. Leukemia. 2019. PMID: 30846865 Free PMC article. No abstract available.

6

[Effects and mechanism on anti-leukemic activity of cytokine-induced killer cells with an endogenous expression of interleukin-21].

Zhao N, Zhao MF, Rajbhandary S, Lu WY, Zhu HB, Ma L, You Q, Xiao X, Deng Q, Li YM. Zhao N, et al. Among authors: ma l. Zhonghua Yi Xue Za Zhi. 2013 Jan 22;93(4):293-9. Zhonghua Yi Xue Za Zhi. 2013. PMID: 23578511 Chinese.

7

CD44 targets Na(+)/H(+) exchanger 1 to mediate MDA-MB-231 cells' metastasis via the regulation of ERK1/2.

Chang G, Wang J, Zhang H, Zhang Y, Wang C, Xu H, Zhang H, Lin Y, Ma L, Li Q, Pang T. Chang G, et al. Among authors: ma l. Br J Cancer. 2014 Feb 18;110(4):916-27. doi: 10.1038/bjc.2013.809. Epub 2014 Jan 16. Br J Cancer. 2014. PMID: 24434427 Free PMC article.

8

Reversal of Imatinib resistance in BCR-ABL-positive leukemia after inhibition of the Na+/H+ exchanger.

Jin W, Li Q, Lin Y, Lu Y, Li H, Wang L, Hu R, Ma L, Wang J, Pang T. Jin W, et al. Among authors: ma l. Cancer Lett. 2011 Sep 1;308(1):81-90. doi: 10.1016/j.canlet.2011.04.016. Epub 2011 May 14. Cancer Lett. 2011. PMID: 21576001

9

CUEDC2 sensitizes chronic myeloid leukemic cells to imatinib treatment.

Zhang H, Chang G, Wang J, Lin Y, Ma L, Pang T. Zhang H, et al. Among authors: ma l. Leuk Res. 2013 Nov;37(11):1583-91. doi: 10.1016/j.leukres.2013.08.019. Epub 2013 Sep 6. Leuk Res. 2013. PMID: 24125838

10

[Driver genes expression and clinical characteristics of targeted therapy in non-small cell lung cancer in Yunnan-Kweichow Plateau].

Lin YP, Li Q, Ma LY, Liu X, Dai M, Wang XX, Li HS, Liu JX, Shen ZH, Guo YJ, Du YX, Yang RJ, Huang YC, Zhou YC. Lin YP, et al. Among authors: ma ly. Zhonghua Zhong Liu Za Zhi. 2020 Sep 23;42(9):735-740. doi: 10.3760/cma.j.cn112152-20200323-00248. Zhonghua Zhong Liu Za Zhi. 2020. PMID: 32988155 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27,372 results

Search Page

Filters